FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Greenstone Spironolactone tablets Recall

Spironolactone tablets, USP 25 mg, Rx only, 500 count bottle, Distributed By: Greenston…

Greenstone Llc · Peapack, NJ

Risk level
Class II
Reported by FDA
Nov 27, 2013
Recall ID
D-010-2014
Check your lot numberHow we source this data

Summary

Greenstone recalled Spironolactone tablets starting Sep 4, 2013. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-010-2014 on Nov 27, 2013. Reason: Marketed without an Approved NDA/ANDA: This recall is being initiated because of changes to the dissolution profile in distributed lots resulting from a manufacturing site change. There is currently no approved application supporting the alternate manufacturing site. Status: Terminated.

Why it was recalled

Marketed without an Approved NDA/ANDA: This recall is being initiated because of changes to the dissolution profile in distributed lots resulting from a manufacturing site change. There is currently no approved application supporting the alternate manufacturing site.

Product description

Spironolactone tablets, USP 25 mg, Rx only, 500 count bottle, Distributed By: Greenstone LLC, Peapack, NJ 07977, NDC: 59762-5011-2.

Lot numbers, UPCs & expiration codes

Lot #: V121207, V121208, Exp 03/31/2017

Where it was sold

Nationwide and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-010-2014
Classification
Class II
Status
Terminated
Recall initiated
Sep 4, 2013
FDA report date
Nov 27, 2013
Quantity
2796 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Greenstone Llc

Original FDA data

Every field from FDA enforcement report D-010-2014, exactly as published.

Show all FDA fields
City
Peapack
State
NJ
Status
Terminated
Country
United States
Event ID
66822
Address
100 Route 206 North
Code information
Lot #: V121207, V121208, Exp 03/31/2017
Postal code
07977
Report date
Nov 27, 2013
Product type
Drugs
Recall number
D-010-2014
Classification
Class II
Recalling firm
Greenstone Llc
Product quantity
2796 bottles
Termination date
Apr 13, 2017
Reason for recall
Marketed without an Approved NDA/ANDA: This recall is being initiated because of changes to the dissolution profile in distributed lots resulting from a manufacturing site change. There is currently no approved application supporting the alternate manufacturing site.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Spironolactone tablets, USP 25 mg, Rx only, 500 count bottle, Distributed By: Greenstone LLC, Peapack, NJ 07977, NDC: 59762-5011-2.
Distribution pattern
Nationwide and Puerto Rico
Recall initiation date
Sep 4, 2013
Initial firm notification
Letter
Center classification date
Nov 20, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-010-2014, published Nov 27, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls